These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11549985)

  • 21. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of treating ocular hypertension.
    Stewart WC; Stewart JA; Nasser QJ; Mychaskiw MA
    Ophthalmology; 2008 Jan; 115(1):94-8. PubMed ID: 18166406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The increased cost of medical services for people diagnosed with primary open-angle glaucoma: a decision analytic approach.
    Kymes SM; Plotzke MR; Li JZ; Nichol MB; Wu J; Fain J
    Am J Ophthalmol; 2010 Jul; 150(1):74-81. PubMed ID: 20493465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: evaluation of brimonidine as a model.
    Abelson MB; Netland PA; Chapin MJ
    Adv Ther; 2001; 18(6):282-97. PubMed ID: 11841198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of early detection and treatment of ocular hypertension and primary open-angle glaucoma by the ophthalmologist.
    Peeters A; Schouten JS; Webers CA; Prins MH; Hendrikse F; Severens JL
    Eye (Lond); 2008 Mar; 22(3):354-62. PubMed ID: 17128205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of glaucoma medical therapy in the Glasgow Glaucoma Database.
    Rahman MQ; Abeysinghe SS; Kelly S; Roskell NS; Shannon PR; Abdlseaed AA; Montgomery DM
    Br J Ophthalmol; 2011 Jul; 95(7):966-70. PubMed ID: 21258080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drugs reactions associated with glaucoma medications.
    Reyes E; Izquierdo NJ; Blasini M
    Bol Asoc Med P R; 1997; 89(4-6):51-5. PubMed ID: 9284599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic impact of primary open-angle glaucoma in Australia.
    Dirani M; Crowston JG; Taylor PS; Moore PT; Rogers S; Pezzullo ML; Keeffe JE; Taylor HR
    Clin Exp Ophthalmol; 2011; 39(7):623-32. PubMed ID: 21631669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of the hypotensive effectiveness of Betoptic preparation].
    Erichev VP; Abdulkadyrova MD; Kalinina OM; Shmyreva VF; Polutornov AL; Egorov EA; Shmeleva IA
    Vestn Oftalmol; 1991; 107(6):8-11. PubMed ID: 1781135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage cost analysis in glaucoma management.
    Gelvin JB; Goen TM
    J Am Optom Assoc; 1989 Oct; 60(10):768-70. PubMed ID: 2584592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospects for neuroprotective glaucoma therapy].
    Grehn F
    Ophthalmologe; 2001 Oct; 98(10):925-8. PubMed ID: 11699312
    [No Abstract]   [Full Text] [Related]  

  • 32. Physicians' guide to interactions between glaucoma and systemic medications.
    Gottfredsdottir MS; Allingham RR; Shields MB
    J Glaucoma; 1997 Dec; 6(6):377-83. PubMed ID: 9407366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximizing cost-effectiveness by adjusting treatment strategy according to glaucoma severity.
    Guedes RAP; Guedes VMP; Gomes CEM; Chaoubah A
    Medicine (Baltimore); 2016 Dec; 95(52):e5745. PubMed ID: 28033286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effectiveness: insights on treatment options for open-angle glaucoma.
    Morse AR; Lee PP
    Arch Ophthalmol; 2012 Apr; 130(4):506-7. PubMed ID: 22491919
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-Utility Analysis of Glaucoma Medication Adherence.
    Newman-Casey PA; Salman M; Lee PP; Gatwood JD
    Ophthalmology; 2020 May; 127(5):589-598. PubMed ID: 31767436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computer-assisted management of primary open-angle glaucoma. Knowledge acquisition and prototype testing.
    Martin L
    Comput Nurs; 1996; 14(5):267-71. PubMed ID: 8870345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.
    Stein JD; Kim DD; Peck WW; Giannetti SM; Hutton DW
    Arch Ophthalmol; 2012 Apr; 130(4):497-505. PubMed ID: 22332202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic keratopathy associated with beta-blocker eyedrops.
    Wilhelmus KR; McCulloch RR; Gross RL
    Cornea; 1990 Oct; 9(4):335-7. PubMed ID: 1981868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of topical prophylactic antiglaucoma therapy in primary closed angle glaucoma in dogs: a multicenter clinical trial.
    Miller PE; Schmidt GM; Vainisi SJ; Swanson JF; Herrmann MK
    J Am Anim Hosp Assoc; 2000; 36(5):431-8. PubMed ID: 10997520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Early Manifest Glaucoma Trial update 2004].
    Erb C
    Ophthalmologe; 2005 Mar; 102(3):219-21. PubMed ID: 15700191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.